Unichem Laboratories gets approval for Zonisamide Capsules

27 Jan 2021 Evaluate

Unichem Laboratories has received Abbreviated New Drug Application (ANDA) approval for its Zonisamide Capsules, USP 25 mg, 50 mg and 100 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Zonegran (Zonisamide) Capsules of Sunovion Pharmaceuticals Inc. Zonisamide Capsules are indicated as adjunctive therapy in the treatment of partial seizures in adults with epilepsy. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

447.15 -6.30 (-1.39%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×